Javelin Pharmaceuticals Inc (JAV)

[y3maxx]

From:... myself...
Sent: Wednesday, May 13, 2009 9:53 AM
To: Driscoll, Martin
Subject: re: Jan 15th/09 Press Release...



Dear Mr. Driscoll,



...I remain a JAV shareholder and I appreciate your own $$$ commitment and vision as a JAV shareholder as well as being JAV's key leader.



We await Ereska top line results.



...FYI, it seems JAV's Market Specialist utilized a delayed Press Release to their advantage for nearly 15 minutes after that morning's market open.



yours truly,

xxx


Response from CEO Driscoll...

Dear Mr. xxx,



Thank you for your support. Now that we have the FDA comments on our Statistical Analysis Plan (SAP) for our Ereska pivotal trial, we are moving forward to do all the work necessary to lock the trial database. Unfortunately, we could not conduct this work until we received the comments.



Our Market Specialist continually frustrates us.



Best regards,



MD



Martin Driscoll

Chief Executive Officer

Javelin Pharmaceuticals, Inc.


--------------------------------------------------------------------------------